Gross Profit Margin (Quarterly) Chart

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 1999. Start Trial.
Date Value
June 30, 2026 12.10%
March 31, 2026 5.39%
December 31, 2025 16.49%
September 30, 2025 8.17%
June 30, 2025 14.15%
March 31, 2025 6.54%
December 31, 2024 17.09%
September 30, 2024 11.96%
June 30, 2024 12.16%
March 31, 2024 3.85%
December 31, 2023 4.20%
September 30, 2023 7.77%
June 30, 2023 12.69%
March 31, 2023 7.23%
December 31, 2022 41.48%
September 30, 2022 12.93%
June 30, 2022 40.31%
March 31, 2022 37.90%
December 31, 2021 15.76%
September 30, 2021 42.54%
June 30, 2021 43.03%
March 31, 2021 40.00%
December 31, 2020 42.62%
September 30, 2020 43.58%
June 30, 2020 40.32%
Date Value
March 31, 2020 39.85%
December 31, 2019 41.14%
September 30, 2019 39.19%
June 30, 2019 39.82%
March 31, 2019 36.36%
December 31, 2018 39.23%
September 30, 2018 40.77%
June 30, 2018 39.38%
March 31, 2018 37.15%
December 31, 2017 39.36%
September 30, 2017 39.34%
June 30, 2017 38.65%
March 31, 2017 36.39%
December 31, 2016 39.07%
September 30, 2016 39.20%
June 30, 2016 39.43%
March 31, 2016 37.82%
December 31, 2015 38.29%
September 30, 2015 37.58%
June 30, 2015 38.63%
March 31, 2015 37.78%
December 31, 2014 39.96%
September 30, 2014 38.49%
June 30, 2014 39.51%
March 31, 2014 39.77%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
HydrogenPro ASA -43.67%
Astec Industries, Inc. 26.17%
Energy Recovery, Inc. 74.67%
Pentair plc 42.35%
Tennant Co. 39.48%